Blueprint Medicines Corporation

(BPMC) Trade

By |

Profile

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.

Contact Information

Website: www.blueprintmedicines.com
Email: info@blueprintmedicines.com
Main Phone: +1 617 374-7580
Address: 45 Sidney Street
Address 2: Suite 3500
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: Jeffrey W. Albers
Employees: 320
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.

Contact Information

Website: www.blueprintmedicines.com
Email: info@blueprintmedicines.com
Main Phone: +1 617 374-7580
Address: 45 Sidney Street
Address 2: Suite 3500
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: Jeffrey W. Albers
Employees: 320
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 80.39 $ -0.57 (-0.70%)
Last Price 80.39 Change $ -0.57 Change % -0.70 Tick N/A
Bid 80.21 Bid Size 200.00 Ask 80.37 Ask Size 100.00
Open 81.00 High 81.50 Low 79.66 Prev Close 80.96
Last Trade Volume 134,548 52 Wk Hi 102.99 52 Wk Low 65.41
Market Cap 4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 49,202,122.00 EPS (TTM) -7.77 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 12 111
Number of Buys 3 21
Number of Sells 9 90
Net Activity -5492 -163354
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Alexis Borisy 1,000
Alexis Borisy 1,000
Alexis Borisy 1,000
Alexis Borisy 1,000
Jeffrey W. Albers 1,000
Jeffrey W. Albers 1,000
Alexis Borisy 1,000
George D. Demetri 1,000
George D. Demetri 1,000
George D. Demetri 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 113 113 113 113
Low Target Price Estimate 66 66 66 66
Mean Target Price Estimate 94.83 93.2 93.2 94.83
Standard Deviation 16.07 17.4 17.4 16.07
Date of Most Recent Estimate 06/04/18 05/17/18 05/17/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 5 5 5
Moderate Buy 1 1 2 2
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.14 1.17 1.21 1.21